NCT03329573 - Bioequivalence Study of Paroxetine Immediate Release (IR) Tablets Manufactured in GlaxoSmithKline Tianjin (GSKT) and Mississauga Sites in Healthy Chinese Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 30, 2018

Primary Completion Date

August 3, 2018

Study Completion Date

August 3, 2018

Conditions

Anxiety Disorders

Interventions

DRUG

Paroxetine IR tablets A

Paroxetine IR tablets A will be the investigational drug. These are film coated tablets with unit dose strength of 20 milligrams (mg) and will be administered via oral route. These tablets will be manufactured in GSKT.

DRUG

Paroxetine IR tablets B

Paroxetine IR tablets B will be the reference drug. These are film coated tablets with unit dose strength of 20 mg and will be administered via oral route. These tablets will be manufactured in Mississauga.

Trial Locations (1)

201508

GSK Investigational Site, Shanghai